Impact of Selected Small-Molecule Kinase Inhibitors on Lipid Membranes
Small-molecule protein kinase inhibitors are used for the treatment of various diseases. Although their effect(s) on the respective kinase are generally quite well understood, surprisingly, their interaction with membranes is only barely investigated; even though these drugs necessarily come into co...
Main Authors: | Meike Luck, Markus Fischer, Maximilian Werle, Holger A. Scheidt, Peter Müller |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-07-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/14/8/746 |
Similar Items
-
Binding of the small-molecule kinase inhibitor ruxolitinib to membranes does not disturb membrane integrity
by: Markus Fischer, et al.
Published: (2020-12-01) -
Subcellular localization of several structurally different tyrosine kinase inhibitors
by: Richard Honeywell, et al.
Published: (2018-09-01) -
Molecular pharmacokinetic determinants of anticancer kinase inhibitors in humans
by: Julie Scholler, et al.
Published: (2011-06-01) -
Membrane Interaction of Ibuprofen with Cholesterol-Containing Lipid Membranes
by: Jan Kremkow, et al.
Published: (2020-09-01) -
Single Lipid Molecule Dynamics on Supported Lipid Bilayers with Membrane Curvature
by: Philip P. Cheney, et al.
Published: (2017-03-01)